Tilapia lake virus: a threat to the global tilapia industry?

Tilapia lake virus (TiLV) is a recently described virus affecting wild and farmed tilapines. At present, it has been reported on three continents (Asia, Africa and South America) and the number of countries where the agent has been detected is likely to increase rapidly as a result of increased awareness, surveillance and availability of diagnostic methods. Any lack of openness regarding the TiLV status of a translocating live tilapia population destined for aquaculture may inadvertently contribute to the spread of the agent. Currently, there is no cure for viral diseases in aquaculture and while vaccines and selective breeding have proved successful in reducing the severity of some viral diseases, there are currently severe knowledge gaps relating to TiLV and no effective, affordable vaccines are yet available. This paper summarizes the published scientific information on TiLV and highlights important issues relating to its diagnosis, mitigation and control measures. While there have been no scientific studies on the socio‐economic impact of TiLV, it may pose a significant threat particularly to small‐scale fish farmers’ livelihoods and wild tilapine populations if left uncontrolled. To aid disease investigations, the authors propose case definitions for suspected and confirmed cases of TiLV infections.